Posted by Dale Buss on February 20, 2012 09:03 AM
Angry Birds is heading to space.
Apple threatens to sue China's Proview over iPad trademark dispute.
Boeing competes for Asia orders worth $10 billion.
Danone and Nestle work to overcome antitrust obstacles in their bids for Pfizer infant-nutrition unit.
David Yurman and other brands see uptick in sales of men's accessories.
Fiat retunes U.S. marketing after 2011 problems while erstwhile spokeswoman Jennifer Lopez turns to lots of other brand deals.
Google launches Latitude Leaderboards, puts Foursquare on notice.Continue reading...
Posted by Dale Buss on February 2, 2012 09:01 AM
American Airlines parent AMR plans to cut 13,000 jobs and pensions.
Apple's iPhone 5 may be coming in June.
Benetton family plans to take retailer private.
Deutsche Bank profit tumbles on European debt crisis.
Facebook sets stage for historic IPO as valuation game begins.
GM cancels half of upfront ad commitments in cost-cutting move.
Google responds to Microsoft criticism of privacy policies.Continue reading...
Posted by Dale Buss on January 25, 2012 09:01 AM
Apple's blockbuster quarter puts iPhone ahead of Google smartphones in the U.S.
Brinker International expands value strategy at Chili's.
Christian Louboutin makes the IP case for its red-soled shoes.
Davos kicks off with worries about eurozone crisis.
Del Frisco's Restaurant plans IPO.
Fiat launches ad for new Panda into Italian austerity zeitgeist.Continue reading...
Posted by Dale Buss on January 18, 2012 09:04 AM
Airbus raises prices of A320neo plane amid strong demand, as Boeing threatens to compete better in 2012 .
AirTran must reinstate whistleblower pilot.
American Express invests $125 million in China mobile payments startup.
Apple eases into corporate market with Macs, while textbook push draws interest.
BankUnited draws bids from TD Bank and others.
Beyonce and Jay-Z challenged by Blue Ivy trademark applicant.
Burberry sales surge on international demand.Continue reading...
Posted by Mark J. Miller on January 5, 2012 05:01 PM
Merck & Co.’s HIV-fighting drug Isentress has been on the market for adults since October of 2007. Now the FDA is letting Merck market the product to children and teens, the Wall Street Journal reports.
Isentress is what’s known as an “HIV integrase inhibitors,” that “work(s) by interfering with the virus's ability to replicate itself,” the Journal notes.
U.S. clinical trials were done with the drug on 96 children and teens between the ages of 2 and 18 years old with HIV. It “found that 53% of these patients had an undetectable amount of HIV in their blood after 24 weeks of treatment with the drug,” WSJ adds.
Merck also is joining five other drug manufacturers to provide discounts on HIV drugs to state drug-assistance programs, according to FiercePharma.com. Starting this week, Merck is discounting Isentress through 2013 to help out the National Alliance of State and Territorial AIDS Directors.
"With the economy the way it is, there are many more people without jobs and many more people who are qualifying for the programs," said Murray Penner, the organization's deputy executive director. "The need has ballooned."
Johnson & Johnson, Bristol-Myers Squibb, Gilead Sciences, Boehringer Ingelheim and the Pfizer/GlaxoSmithKline joint venture ViiV Healthcare have all also discounted drugs for the state programs.
Posted by Dale Buss on December 13, 2011 08:55 AM
AOL reorganizes into four business units.
Apple softens stance to lure mobile ads, as iAds seen as rare failure for Steve Jobs.
AT&T deal with T-Mobile granted a delay by judge.
BBC to make World News available through Comcast.
China Mobile tops Millward Brown ranking of Chinese brands.
Deloitte sees gamification as one of the top tech trends of 2012.
Facebook seen as not needing Wall Street to go public; tests private messages between people and pages.
HP dumps its iPad rival on eBay.
IHOP opens fast-casual IHOP Express.
Ikea sues Irish home retailer for allegedly copying prints.
Intel tells customers they can turn up the heat in server rooms.
Interbrand named branding agency of the year by Marketing magazine.Continue reading...
Posted by Mark J. Miller on December 1, 2011 02:59 PM
The drug Lipitor has made Pfizer so much dough that it isn’t planning to just turn its attention to newer products now that the drug can be sold generically as of Wednesday, according to the Associated Press.
The problem is that Pfizer doesn’t have anything new that can make up for the $11 billion that Lipitor brings in, the AP points out, so it is doing everything it can to hang onto the customers it has.
The AP has it that when a drug goes generic, the revenue that is has been pulling in from that drug generally disappears for the most part within a year, but Pfizer has bought itself about six months by “devis(ing) discounts and incentives for patients, insurers and companies that process prescriptions” that will “make the brand name drug about as cheap as or cheaper than the generics.”Continue reading...
Posted by Dale Buss on November 30, 2011 08:55 AM
ABC dismisses rumors of Pan Am's demise.
Amazon continues being coy about Kindle sales.
Apple's Siri can handle Viagra but not abortions.
AT&T disturbed by FCC report.
Audi finds success with youthful marketing.
BBC web redesign goes live in the UK.
Carlsberg acquires Vietnamese brewer.
Google and Facebook ordered to de-index counterfeit domains.
Jack Daniel's holiday campaign celebrates brand's Lynchburg, Tenn. roots.
Janet Jackson teams up with Blackglama to design luxury fur line.
Microsoft Office is reportedly coming to the iPad as Windows tablet hopes fade.Continue reading...